Keyphrases
Diverse Populations
100%
Enterotoxigenic Escherichia Coli
100%
Seroprevalence Survey
100%
Endemic Region
50%
EtpA
50%
Escherichia Coli Infections
33%
Haitian children
33%
Immune Response
16%
Bangladesh
16%
Young children
16%
US children
16%
Low-middle Income Countries
16%
Intestinal Colonization
16%
Heat-labile Toxin
16%
Immunogenicity
16%
Escherichia Coli Vaccines
16%
Common Cause
16%
US Adults
16%
Vaccine Antigen
16%
Enterotoxin
16%
Vaccine Strategy
16%
Egypt
16%
Peru
16%
Wide Distribution
16%
Serological Response
16%
IgG Response
16%
Mandatory Vaccines
16%
Cameroon
16%
Enhanced Efficacy
16%
Infectious Diarrhea
16%
IgA Responses
16%
Travellers
16%
Conserved Antigens
16%
Childhood Diarrhea
16%
Travelers' Diarrhea
16%
Controlled Human Infection Model
16%
Medicine and Dentistry
Seroprevalence
100%
Enterotoxigenic Escherichia Coli
100%
Escherichia Coli Infection
33%
Infection
16%
Immune Response
16%
Toddlers
16%
Low and Middle Income Countries
16%
Immunogenicity
16%
Immunoglobulin A
16%
Infectious Diarrhea
16%
Escherichia Coli Vaccine
16%
Enterotoxin
16%
Traveller Diarrhea
16%
Pharmacology, Toxicology and Pharmaceutical Science
Enterotoxigenic Escherichia Coli
100%
Seroprevalence
100%
Escherichia Coli Infection
33%
Infection
16%
Escherichia Coli Vaccine
16%
Immunogenicity
16%
Enterotoxin
16%
Immunoglobulin A
16%
Infectious Diarrhea
16%
Traveller Diarrhea
16%
Immunology and Microbiology
Enterotoxigenic Escherichia Coli
100%
Seroprevalence
100%
Immune Response
16%
Escherichia Coli Vaccine
16%
Enterotoxin
16%
Immunogenicity
16%
Immunoglobulin A
16%
Biochemistry, Genetics and Molecular Biology
Enterotoxigenic Escherichia Coli
100%
Seroprevalence
100%
Immune Response
16%
Immunogenicity
16%
Immunoglobulin A
16%
Enterotoxin
16%